NZ727749A - Use of anti-aging glycopeptides to enhance beta cell health, survival and improve transplant outcome - Google Patents

Use of anti-aging glycopeptides to enhance beta cell health, survival and improve transplant outcome

Info

Publication number
NZ727749A
NZ727749A NZ727749A NZ72774915A NZ727749A NZ 727749 A NZ727749 A NZ 727749A NZ 727749 A NZ727749 A NZ 727749A NZ 72774915 A NZ72774915 A NZ 72774915A NZ 727749 A NZ727749 A NZ 727749A
Authority
NZ
New Zealand
Prior art keywords
survival
beta cell
cell health
transplant outcome
enhance beta
Prior art date
Application number
NZ727749A
Other languages
English (en)
Inventor
Lachlan Grant Young
A M James Shapiro
Original Assignee
Protokinetix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protokinetix Inc filed Critical Protokinetix Inc
Publication of NZ727749A publication Critical patent/NZ727749A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NZ727749A 2014-06-04 2015-06-02 Use of anti-aging glycopeptides to enhance beta cell health, survival and improve transplant outcome NZ727749A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462007626P 2014-06-04 2014-06-04
PCT/CA2015/050509 WO2015184544A1 (en) 2014-06-04 2015-06-02 Use of anti-aging glycopeptides to enhance pancreatic cell health, survival and improve transplant outcome

Publications (1)

Publication Number Publication Date
NZ727749A true NZ727749A (en) 2023-04-28

Family

ID=54765902

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ727749A NZ727749A (en) 2014-06-04 2015-06-02 Use of anti-aging glycopeptides to enhance beta cell health, survival and improve transplant outcome

Country Status (8)

Country Link
US (4) US20150352155A1 (enExample)
EP (1) EP3152297A4 (enExample)
JP (1) JP6801934B2 (enExample)
KR (1) KR102411834B1 (enExample)
CN (1) CN106661549B (enExample)
AU (1) AU2015271608B9 (enExample)
NZ (1) NZ727749A (enExample)
WO (1) WO2015184544A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3407876B1 (en) 2016-01-27 2022-01-12 Protokinetix Inc. Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
SI3411047T1 (sl) 2016-02-04 2021-09-30 Czap Research And Development, Llc Sredstva za nadzorovano sproščeni in stratificirani kompleks vključitve ciklodekstrina
KR20220137037A (ko) * 2020-01-24 2022-10-11 프로토키네틱스 인코포레이티드 이식편의 면역 거부의 억제를 위한 항-노화 글리코펩타이드들의 사용
CN115568282A (zh) * 2020-03-10 2023-01-03 普罗托基尼蒂克有限公司 抗衰老糖肽治疗干眼症、视网膜退行性疾病或眼部炎症的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878851B1 (fr) * 2004-12-02 2007-02-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation en cryochirurgie et/ou cryopreservation
FR2900656A1 (fr) * 2006-05-03 2007-11-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation notamment pour la preservation de materiaux biologiques

Also Published As

Publication number Publication date
JP2017520275A (ja) 2017-07-27
EP3152297A1 (en) 2017-04-12
JP6801934B2 (ja) 2020-12-16
US20170360844A1 (en) 2017-12-21
CA2950963A1 (en) 2015-12-10
KR102411834B1 (ko) 2022-06-21
CN106661549A (zh) 2017-05-10
AU2015271608A1 (en) 2017-01-12
WO2015184544A1 (en) 2015-12-10
US20230414675A1 (en) 2023-12-28
AU2015271608B2 (en) 2021-05-27
KR20170023029A (ko) 2017-03-02
US20150352155A1 (en) 2015-12-10
EP3152297A4 (en) 2018-01-31
AU2015271608B9 (en) 2021-06-17
CN106661549B (zh) 2022-02-11
US20210023142A1 (en) 2021-01-28

Similar Documents

Publication Publication Date Title
ZA201608303B (en) Methods for harvesting mammalian cell cultures
IL282637A (en) Methods for allogeneic transplantation of hematopoietic stem cells
MX2021003311A (es) Sondas para la proyeccion de imagen de la proteina huntingtina.
PH12017500720A1 (en) Glycopeptide compositions
NZ726989A (en) Improved t cell compositions
EP3254329A4 (en) Electrochemical cells that include lewis acid: lewis base complex electrolyte additives
EP4265250A3 (en) Solid forms of an ask1 inhibitor
MX2022013114A (es) Inhibidores de diana de rapamicina en celulas de mamifero de complejo 1 (mtorc1).
MX339533B (es) Composiciones y metodos de daclizumab (dac) del proceso de alto rendimiento (hyp).
EA201301130A1 (ru) Имидазопиридазины в качестве ингибиторов акт киназы
EP3138399A4 (en) Composition for organ, tissue, or cell transplantation, kit, and transplantation method
ZA201605566B (en) Method of operating electrochemical cells comprising electrodeposited fuel
IL257678A (en) Methods of stem cell transplantation
EP3048169A4 (en) Method for preparing pluripotent stem cells
IN2014CN04598A (enExample)
MX2015009818A (es) Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple.
MX2017002705A (es) Sondas para la proyección de imagen de la proteína huntingtina.
PH12016502418B1 (en) Rocuronium preparation with improved stability
SG10201913752PA (en) Methods and compositions for stem cell transplantation
NZ722412A (en) Methods of preparing a hydrochloride salt of (1r,2r,5r)-5-amino-2-methylcyclohexanol
NZ727749A (en) Use of anti-aging glycopeptides to enhance beta cell health, survival and improve transplant outcome
EP3181686A4 (en) Culture medium and method for enriching and maintaining cancer stem cells (cscs) using said medium
PH12016501704A1 (en) Method for producing 2-acyliminopyridine derivative
KR101985095B9 (ko) 에티오나마이드를 이용한 줄기세포 증식능 향상 방법
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.

Legal Events

Date Code Title Description
S35A Application for proceedings under section 35 (restoration of lapsed patents)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 JUN 2025 BY CATALYST INTELLECTUAL PROPERTY LIMITED

Effective date: 20240510

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 JUN 2026 BY CATALYST INTELLECTUAL PROPERTY LIMITED

Effective date: 20250403